|
Enamine Ltd was founded in 1991 with the advent of high throughput screening in early drug discovery. The driving force of the company’s development was rapidly increasing demand for new chemical compounds. In over 15 years Enamine has become a global provider of Screening Compounds, Building Blocks, and Fragments for supporting a wide range of research programs conducted by pharmaceutical and biotech companies, drug discovery centers, academic institutions and other research organizations worldwide.
Building blocks can be used in medicinal chemistry and drug discovery. Full database (20 556 947 structures) and other relevant …
Our screening collection currently contains 2 725 753 low molecular weight organic compounds. All Enamine screening compounds are grouped into …
Our catalogue currently contains 1 006 155 building blocks including 225 000 compounds in stock, which can be delivered within …
This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality